心室頻拍(Ventricular Tachycardia)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Ventricular Tachycardia 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials and Average Enrollment by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Unaccomplished Trials of Ventricular Tachycardia 27
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Ventricular Tachycardia Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Gilead Sciences, Inc. 35
Clinical Trial Overview of Gilead Sciences, Inc. 35
Baxter International Inc. 36
Clinical Trial Overview of Baxter International Inc. 36
Milestone Pharmaceuticals, Inc. 37
Clinical Trial Overview of Milestone Pharmaceuticals, Inc. 37
Jiangsu Furui Pharmaceuticals Co., Ltd 38
Clinical Trial Overview of Jiangsu Furui Pharmaceuticals Co., Ltd 38
Gilead Sciences 39
Clinical Trial Overview of Gilead Sciences 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Aop Orphan Pharmaceuticals AG 41
Clinical Trial Overview of Aop Orphan Pharmaceuticals AG 41
Actavis plc 42
Clinical Trial Overview of Actavis plc 42
Clinical Trial Overview of Top Institutes / Government 43
Institut de Recherches Internationales Servier 43
Clinical Trial Overview of Institut de Recherches Internationales Servier 43
Meshalkin Research Institute of Pathology of Circulation 44
Clinical Trial Overview of Meshalkin Research Institute of Pathology of Circulation 44
Aalborg University Hospital 45
Clinical Trial Overview of Aalborg University Hospital 45
Assistance Publique – Hopitaux de Paris 46
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 46
Beaumont Health System 47
Clinical Trial Overview of Beaumont Health System 47
Capital District Health Authority, Canada 48
Clinical Trial Overview of Capital District Health Authority, Canada 48
Central Finland Hospital District 49
Clinical Trial Overview of Central Finland Hospital District 49
Department of Health, UK 50
Clinical Trial Overview of Department of Health, UK 50
Duke University 51
Clinical Trial Overview of Duke University 51
El Hospital General Universitario Gregorio Maranon 52
Clinical Trial Overview of El Hospital General Universitario Gregorio Maranon 52
Five Key Clinical Profiles 53
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 81